FDA-AstraZeneca Hearing
Similar Posts
Sharav / Cassidy – OHRP Testimony, 4/01
Testimony Submitted to the Office of Human Research Protection (OHRP) by Vera Hassner Sharav and Marie M. Cassidy, Ph.D, D.Sc. April, 2001 AHRP recognizes that to include children in clinical trials for any medication presents a dilemma of truly Solomonic proportions. It is a choice between continuing the practice of…
InfoMail for April 19, 2002
AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav April 19, 2002 DHHS / FDA flip-flopsecond time re: " pediatric rule" FYI Tommy Thompson, Secretary of The Department of Health andHuman Services has reversed the FDA’s…
Rebecca Riley’s doctor now the target of a grand jury
The Patriot Ledger reports that Rebecca Riley’s psychiatrist, Dr. Kayoko Kifuji, is under criminal investigation by a grand jury.
Should the EPA Accept Human Pesticide Experiments?
Testimony by Vera Hassner Sharav before the Committee on the Use of Third Party Toxicity Research with Human Research Participants; Science, Technology, and Law Program; The National Academies of Science Committee on the Use of Third Party Toxicity Research with Human Research Participants
My name is Vera Sharav and I am the president and founder of The Alliance for Human Research Protection (AHRP) a citizens’ watchdog organization monitoring human research to ensure that the moral principles enshrined in the Nuremberg Code and the Declaration of Helsinki are preserved and followed in experiments involving human beings.
Scientific American: Preparing for a Pandemic
Scientific American: Preparing for a Pandemic Wed, 26 Oct 2005 An article in Scientific American (excerpt below) provides a totally different explanation of a pandemic influenza outbreak than that offered in reports sent in yesterday’s Infomail. Two sites have been highly recommended for reliable information: FLU WIKI: http://www.fluwikie.com/ and EFFECT…
Unreported Paxil suicides: company abandons "No Addiction" claim
Unreported Paxil suicides: company abandons “No Addiction” claim Sat, 10 May 2003 GlaxoSmithKline, Britain’s biggest pharmaceutical company will change the label in the UK to reflect the severe withdrawal that its antidepressant drug, Seroxat (Paxil in US) generates in many patients. In Britain, the package label will no longer claim…